To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene HPCAL1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
467 supporting clones for gene HPCAL1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BU145561 dorsal root ganglia .a 1 to 879 1 to 881 exact tiling clone,   881/882
(99 %)
11 diff
(98.8 %id)
BG714247 brain, hypothalamus .b 1 to 672 1 to 673   tiling clone,   673/673
(100 %)
8 diff
(98.9 %id)
BG714587 brain, hypothalamus .b 15 to 516 1 to 503       503/503
(100 %)
7 diff
(98.7 %id)
BI601950 brain, hypothalamus .b 16 to 771 1 to 757 P39T I170H R171Q G172R A173C ... tiling clone,   757/757
(100 %)
7 diff
(99.1 %id)
TI_45209693   .b 17 to 771 128 to 879 P39T I170H R171Q G172R A173C ...     752/879
(85 %)
10 diff
(98.9 %id)
BX376943 Neuroblastoma Cot 50-normalized .c 1 to 1091 1 to 1081 F64X T92X S143F T158X S165X ... tiling clone,   1081/1086
(99 %)
51 diff
(95.4 %id)
DA385051 thalamus .d 1 to 570 2 to 571   tiling clone, capped   570/570
(100 %)
1 diff
(99.9 %id)
DA377802 thalamus .d 247 to 873 2 to 628   tiling clone, capped   627/627
(100 %)
2 diff
(99.7 %id)
DB311610 thalamus .d 1463 to 2003 541 to 1   tiling clone,   541/541
(100 %)
0 diff
(100 %id)
DC312991 amygdala .e 1 to 569 1 to 569   tiling clone,   569/569
(100 %)
4 diff
(99.3 %id)
DC330075 hippocampus .e 17 to 591 1 to 575       575/575
(100 %)
2 diff
(99.7 %id)
DC315794 amygdala .e 127 to 677 1 to 551       551/551
(100 %)
0 diff
(100 %id)
BI668079 brain, hypothalamus .e 171 to 1040 1 to 861   tiling clone,   861/861
(100 %)
25 diff
(97.1 %id)
TI_44346488   .e 171 to 1040 90 to 950       861/950
(90 %)
25 diff
(97.4 %id)
BG717619 testis .e 174 to 740 7 to 581       575/665
(86 %)
18 diff
(97.3 %id)
DB489047 hypothalamus .e 177 to 619 1 to 442       442/442
(100 %)
3 diff
(99.4 %id)
DB506511 hypothalamus .e 177 to 645 1 to 469       469/470
(99 %)
3 diff
(99.4 %id)
AK292280 testis .e 200 to 1615 1 to 1416 exact tiling clone,   1416/1416
(100 %)
2 diff
(99.9 %id)
DC396039 testis .e 200 to 790 1 to 591       591/591
(100 %)
0 diff
(100 %id)
DC394778 testis .e 212 to 740 1 to 529       529/535
(98 %)
4 diff
(99.3 %id)
DC396281 testis .e 216 to 739 1 to 524       524/554
(94 %)
4 diff
(99.3 %id)
DC399349 testis .e 218 to 784 1 to 567       567/567
(100 %)
0 diff
(100 %id)
DC425824 amygdala .e 1580 to 2125 546 to 1   tiling clone,   546/546
(100 %)
1 diff
(99.9 %id)
BU846171 ovary, teratocarcinoma, cell line .f -11 to 738 1 to 750       750/887
(84 %)
6 diff
(99.4 %id)
BU859245 ovary, teratocarcinoma, cell line .f -11 to 778 1 to 792   tiling clone,   792/907
(87 %)
7 diff
(99.3 %id)
DA692361   .f -11 to 265 2 to 278   capped   277/277
(100 %)
1 diff
(99.7 %id)
BM473914 melanotic melanoma, skin .f -9 to 852 1 to 868       868/1123
(77 %)
20 diff
(98.3 %id)
BI756866 brain .f -8 to 382 1 to 388       388/388
(100 %)
4 diff
(99.0 %id)
BE876008 large cell carcinoma, undifferentiated, lung .f 1 to 738 9 to 744       744/853
(87 %)
21 diff
(97.6 %id)
BQ689877 ductal carcinoma, cell line, Pancreas .f 1 to 852 7 to 861       861/985
(87 %)
15 diff
(98.5 %id)
BQ685349 ductal carcinoma, cell line, Pancreas .f 1 to 798 7 to 809       809/913
(88 %)
18 diff
(98.1 %id)
TI_57168024   .f 1 to 628 30 to 686       662/757
(87 %)
33 diff
(95.7 %id)
BC009846 Brain, neuroblastoma .f 1 to 1728 1 to 1728 exact available from MGC, AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 1728/1728
(100 %)
2 diff
(99.9 %id)
DA055469 cerebellum .f 1 to 499 2 to 501   capped   500/500
(100 %)
1 diff
(99.8 %id)
BM548058 brain, hippocampus .f 1 to 620 16 to 636       621/1047
(59 %)
12 diff
(98.9 %id)
BU500753   .f 1 to 738 1 to 738       738/888
(83 %)
4 diff
(99.6 %id)
BX419653 brain, fetal brain .f 4 to 685 1 to 684       684/737
(92 %)
23 diff
(96.9 %id)
BE777934 eye, retinoblastoma .f 5 to 814 1 to 805       805/929
(86 %)
32 diff
(96.6 %id)
CR594189 Neuroblastoma Cot 10-normalized .f 8 to 1695 1 to 1688 exact     1688/1688
(100 %)
0 diff
(100 %id)
CR613842 Neuroblastoma Cot 25-normalized .f 8 to 1691 1 to 1684 exact     1684/1684
(100 %)
0 diff
(100 %id)
AL521769 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .f 8 to 872 1 to 864   fully sequenced,   864/864
(100 %)
2 diff
(99.8 %id)
BX374701 Neuroblastoma Cot 25-normalized .f 8 to 844 1 to 836       836/836
(100 %)
8 diff
(99.1 %id)
AL524444 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .f 8 to 874 1 to 866   fully sequenced,   866/866
(100 %)
2 diff
(99.8 %id)
BG576950 breast, mammary adenocarcinoma, cell line .f 8 to 686 1 to 679       679/679
(100 %)
1 diff
(99.9 %id)
BC017028 Pancreas, epithelioid carcinoma .f 9 to 1716 1 to 1708 exact available from MGC, AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 1708/1708
(100 %)
1 diff
(100.0 %id)
AL555402 placenta .f 10 to 803 1 to 793   fully sequenced,   793/793
(100 %)
5 diff
(99.4 %id)
BM462631 melanotic melanoma, skin .f 10 to 711 1 to 703       703/1009
(69 %)
8 diff
(99.3 %id)
BQ716246 sympathetic trunk .f 10 to 632 1 to 629       629/1042
(60 %)
12 diff
(98.9 %id)
CR599915 HeLa cells Cot 25-normalized .f 11 to 1691 1 to 1681 exact     1681/1681
(100 %)
0 diff
(100 %id)
BF338859 brain, glioblastoma with EGFR amplification .f 16 to 737 1 to 717       717/766
(93 %)
9 diff
(98.9 %id)
BE905604 epithelioid carcinoma, Pancreas .f 30 to 651 1 to 622       622/622
(100 %)
6 diff
(99.1 %id)
BE906918 epithelioid carcinoma, Pancreas .f 30 to 644 1 to 614       614/614
(100 %)
1 diff
(99.9 %id)
BE892941 melanotic melanoma, skin .f 30 to 804 1 to 783       783/798
(98 %)
27 diff
(96.7 %id)
DA561090 heart .f 55 to 616 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
DA541533 lung .f 56 to 611 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA063987 cerebellum .f 59 to 615 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA139843 alzheimer cortex .f 59 to 620 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB483444 hippocampus .f 59 to 520 1 to 462       462/462
(100 %)
5 diff
(99.0 %id)
DA064129 cerebellum .f 61 to 632 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BG911946 anaplastic oligodendroglioma with 1p/19qloss, brain .f 64 to 532 1 to 471       471/473
(99 %)
6 diff
(98.8 %id)
BI597950 brain, hypothalamus .f 76 to 605 115 to 647       533/648
(82 %)
8 diff
(98.8 %id)
TI_45214517   .f 76 to 605 202 to 734       533/735
(72 %)
8 diff
(99.0 %id)
BQ720159 sympathetic trunk .f 95 to 977 1 to 892 M136T K137E T144P E146G K147E ...     892/910
(98 %)
31 diff
(96.6 %id)
CT003823 T-Lymphocytes .f 125 to 921 1 to 797       797/800
(99 %)
1 diff
(99.9 %id)
DR007169 Spleen .f 171 to 872 1 to 700       700/700
(100 %)
8 diff
(98.9 %id)
TI_57178832   .f 242 to 1020 22 to 807 L97H E98G Q99C K100R L101S ...     786/807
(97 %)
16 diff
(98.1 %id)
BI457075 epithelioid carcinoma cell line, Pancreas .f 244 to 612 298 to 663       663/667
(99 %)
15 diff
(97.8 %id)
TI_45133309   .f 244 to 612 358 to 723       662/666
(99 %)
14 diff
(97.9 %id)
BX391958   .f 247 to 996 748 to 1 exact     748/798
(93 %)
4 diff
(99.5 %id)
BG335578 choriocarcinoma, placenta .f 247 to 809 290 to 852       563/1124
(50 %)
45 diff
(96.0 %id)
BU500175   .f 247 to 1001 23 to 786 S165V E167X E168R F169X I170H ...     764/824
(92 %)
25 diff
(97.0 %id)
BI767026 pooled lung and spleen .f 249 to 1020 1 to 779 L97H E98G Q99C K100R L101S ...     779/779
(100 %)
11 diff
(98.6 %id)
BC017482 Placenta, choriocarcinoma .f 250 to 1728 265 to 1743 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 1743/1743
(100 %)
1 diff
(100.0 %id)
DA057361 cerebellum .f 250 to 460 287 to 497   capped   496/496
(100 %)
1 diff
(99.8 %id)
DA057723 cerebellum .f 250 to 460 298 to 508   capped   507/507
(100 %)
2 diff
(99.7 %id)
DA062078 cerebellum .f 250 to 269 276 to 295   capped   294/294
(100 %)
2 diff
(99.4 %id)
DA069896 cerebellum .f 250 to 306 290 to 346   capped   345/346
(99 %)
1 diff
(99.8 %id)
DA079092 cerebellum .f 250 to 270 275 to 295   capped   294/294
(100 %)
0 diff
(100 %id)
DA085102 cerebellum .f 250 to 309 291 to 350   capped   349/349
(100 %)
2 diff
(99.5 %id)
DA086561 cerebellum .f 250 to 262 290 to 302   capped   301/301
(100 %)
0 diff
(100 %id)
DA096410 cerebellum .f 250 to 528 294 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA159561 amygdala .f 250 to 257 275 to 282   capped   281/281
(100 %)
0 diff
(100 %id)
DA198604 brain .f 250 to 400 300 to 450   capped   449/449
(100 %)
2 diff
(99.6 %id)
DA343129 substantia nigra .f 250 to 562 275 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
DA384378 thalamus .f 250 to 543 298 to 591   capped   590/590
(100 %)
1 diff
(99.9 %id)
CR593075 HeLa cells Cot 25-normalized .f 250 to 1704 272 to 1726 exact     1726/1726
(100 %)
0 diff
(100 %id)
CR605568 Neuroblastoma Cot 50-normalized .f 250 to 1678 274 to 1702 exact     1702/1702
(100 %)
0 diff
(100 %id)
CR616250 HeLa cells Cot 25-normalized .f 250 to 1695 263 to 1708 exact     1708/1708
(100 %)
0 diff
(100 %id)
CR623935 Neuroblastoma Cot 10-normalized .f 250 to 1694 272 to 1716 exact     1716/1716
(100 %)
0 diff
(100 %id)
AL520806 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .f 250 to 825 270 to 846   fully sequenced,   846/846
(100 %)
7 diff
(99.2 %id)
BX332646 Neuroblastoma Cot 25-normalized .f 250 to 785 311 to 846       846/846
(100 %)
36 diff
(95.8 %id)
BX386978 Neuroblastoma Cot 50-normalized .f 250 to 889 287 to 928       928/931
(99 %)
21 diff
(97.8 %id)
AL530536 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .f 250 to 1021 273 to 1035 Y108X N113X G114X Y115X M121K ... fully sequenced,   1035/1035
(100 %)
11 diff
(99.0 %id)
BX421962 T cells (Jurkat cell line) .f 250 to 734 284 to 768       768/768
(100 %)
2 diff
(99.8 %id)
AL559176 T cells from T cell leukemia .f 250 to 789 266 to 805       805/805
(100 %)
5 diff
(99.4 %id)
BX384422   .f 250 to 981 272 to 994 D157X E168X Q184A C185V D186R ... fully sequenced,   994/994
(100 %)
7 diff
(99.3 %id)
AL556915 placenta .f 250 to 886 262 to 897       897/897
(100 %)
8 diff
(99.2 %id)
CA389547 eye, RPE/choroid .f 250 to 639 274 to 663     Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 663/663
(100 %)
0 diff
(100 %id)
D16227 brain .f 250 to 1185 39 to 968 N19K A88G S93R R94G     907/968
(93 %)
23 diff
(97.7 %id)
DB483479 hippocampus .f 250 to 428 275 to 453       453/453
(100 %)
6 diff
(98.7 %id)
DB483814 hippocampus .f 250 to 436 275 to 461       461/461
(100 %)
2 diff
(99.6 %id)
DB489896 hypothalamus .f 250 to 424 275 to 449       449/450
(99 %)
7 diff
(98.5 %id)
DB493271 hypothalamus .f 250 to 471 275 to 496       496/496
(100 %)
3 diff
(99.4 %id)
DB493825 hypothalamus .f 250 to 478 275 to 503       503/504
(99 %)
6 diff
(98.9 %id)
DB498981 hypothalamus .f 250 to 447 300 to 497       497/497
(100 %)
2 diff
(99.6 %id)
DB499255 hypothalamus .f 250 to 459 275 to 484       484/484
(100 %)
3 diff
(99.4 %id)
DB501123 hypothalamus .f 250 to 447 300 to 497       497/497
(100 %)
2 diff
(99.6 %id)
DB501867 hypothalamus .f 250 to 424 300 to 474       474/474
(100 %)
3 diff
(99.4 %id)
DB503952 hypothalamus .f 250 to 435 300 to 485       485/485
(100 %)
3 diff
(99.4 %id)
DA560827 heart .f 250 to 513 302 to 565   capped   564/564
(100 %)
3 diff
(99.5 %id)
CN484061 eye .f 250 to 549 272 to 572       572/572
(100 %)
3 diff
(99.5 %id)
AW630911 2 pooled high-grade transitional celltumors, genitourinary tract .f 250 to 461 284 to 495     Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 495/495
(100 %)
15 diff
(97.0 %id)
BF184539 bone marrow, from chronic myelogenous leukemia .f 250 to 547 266 to 560       560/560
(100 %)
8 diff
(98.6 %id)
BG036873 brain, hippocampus .f 250 to 627 302 to 684       684/844
(81 %)
18 diff
(97.9 %id)
BG032674 breast, mammary adenocarcinoma, cell line .f 250 to 510 278 to 538       538/538
(100 %)
2 diff
(99.7 %id)
BG252981 adenocarcinoma, cell line, Liver .f 250 to 689 305 to 743       743/744
(99 %)
3 diff
(99.6 %id)
BG281107 melanotic melanoma, skin .f 250 to 844 276 to 895       856/947
(90 %)
50 diff
(94.8 %id)
BG332597 large cell carcinoma, lung .f 250 to 743 282 to 767       767/877
(87 %)
19 diff
(97.9 %id)
BG332182 large cell carcinoma, lung .f 250 to 742 277 to 764       764/929
(82 %)
35 diff
(96.3 %id)
BG489649 large cell carcinoma, lung .f 250 to 832 266 to 857       855/859
(99 %)
27 diff
(96.9 %id)
BG481893 choriocarcinoma, placenta .f 250 to 773 266 to 790       790/790
(100 %)
1 diff
(99.9 %id)
BG479730 choriocarcinoma, placenta .f 250 to 774 266 to 796       796/796
(100 %)
16 diff
(98.0 %id)
BG707091 brain, hypothalamus .f 250 to 738 280 to 772       772/832
(92 %)
11 diff
(98.7 %id)
BG706586 brain, hypothalamus .f 250 to 597 281 to 630       630/631
(99 %)
11 diff
(98.3 %id)
BG704380 brain, hippocampus .f 250 to 592 277 to 619       619/619
(100 %)
10 diff
(98.4 %id)
BI161270 epithelioid carcinoma cell line, Pancreas .f 250 to 720 271 to 742       742/742
(100 %)
10 diff
(98.7 %id)
BI517513 pooled colon, kidney, stomach .f 250 to 699 267 to 722       722/761
(94 %)
14 diff
(98.2 %id)
BI824897 pooled brain, lung, testis .f 250 to 635 301 to 694       672/694
(96 %)
22 diff
(96.9 %id)
BI822951 pooled brain, lung, testis .f 250 to 707 265 to 721       721/721
(100 %)
3 diff
(99.6 %id)
BI823424 pooled brain, lung, testis .f 250 to 792 272 to 817       817/817
(100 %)
14 diff
(98.3 %id)
BI763951 pooled colon, kidney, stomach .f 250 to 772 266 to 786       786/786
(100 %)
5 diff
(99.4 %id)
BI910727 leukocyte .f 250 to 752 285 to 790       790/790
(100 %)
6 diff
(99.3 %id)
BI552757 brain, hippocampus .f 250 to 842 269 to 862       862/928
(92 %)
13 diff
(98.6 %id)
BI459104 testis .f 250 to 658 268 to 677       677/677
(100 %)
12 diff
(98.3 %id)
BI458318 brain, hypothalamus .f 250 to 791 280 to 828       828/828
(100 %)
16 diff
(98.1 %id)
BI601322 brain, hypothalamus .f 250 to 724 280 to 756       756/871
(86 %)
8 diff
(99.1 %id)
BI559731 testis .f 250 to 787 280 to 821       821/824
(99 %)
12 diff
(98.6 %id)
BI599711 brain, hypothalamus .f 250 to 726 302 to 782       777/782
(99 %)
20 diff
(97.5 %id)
BI601699 brain, hypothalamus .f 250 to 789 280 to 822       822/825
(99 %)
18 diff
(97.9 %id)
BI597151 brain, hypothalamus .f 250 to 747 305 to 806       806/806
(100 %)
21 diff
(97.4 %id)
BI603158 brain, hypothalamus .f 250 to 844 280 to 872       872/915
(95 %)
24 diff
(97.4 %id)
BI669931 brain, hypothalamus .f 250 to 635 280 to 665       665/665
(100 %)
7 diff
(99.0 %id)
BI669192 brain, hypothalamus .f 250 to 477 305 to 533       526/533
(98 %)
8 diff
(98.5 %id)
BM545256 brain, hippocampus .f 250 to 724 290 to 762       743/1126
(65 %)
20 diff
(98.3 %id)
BM545424 brain, hippocampus .f 250 to 552 389 to 696       586/1306
(44 %)
21 diff
(98.4 %id)
BU167326 melanotic melanoma, skin .f 250 to 656 275 to 687       687/870
(78 %)
14 diff
(98.4 %id)
BQ926519 large cell carcinoma, lung .f 250 to 642 281 to 676       676/936
(72 %)
13 diff
(98.7 %id)
BU528514 epidermoid carcinoma, cell line, lung .f 250 to 539 270 to 561       561/816
(68 %)
21 diff
(97.5 %id)
BU855629 ovary, teratocarcinoma, cell line .f 250 to 742 305 to 796       764/928
(82 %)
23 diff
(97.6 %id)
TI_57220115   .f 250 to 738 285 to 762       741/775
(95 %)
21 diff
(97.3 %id)
TI_57196171   .f 250 to 635 301 to 694       672/694
(96 %)
22 diff
(96.9 %id)
TI_57202157   .f 250 to 707 304 to 760       727/760
(95 %)
9 diff
(98.9 %id)
TI_57202777   .f 250 to 792 308 to 853       825/853
(96 %)
19 diff
(97.8 %id)
TI_45235863   .f 250 to 699 332 to 787       728/826
(88 %)
25 diff
(97.0 %id)
TI_57151845   .f 250 to 772 298 to 818       791/818
(96 %)
11 diff
(98.7 %id)
TI_57237478   .f 250 to 752 318 to 823       790/823
(95 %)
12 diff
(98.6 %id)
TI_44170559   .f 250 to 842 391 to 984       860/1050
(81 %)
15 diff
(98.6 %id)
TI_45210649   .f 250 to 724 367 to 843       759/958
(79 %)
10 diff
(99.0 %id)
TI_45213060   .f 250 to 726 383 to 863       777/863
(90 %)
20 diff
(97.7 %id)
TI_45214755   .f 250 to 789 368 to 910       825/913
(90 %)
17 diff
(98.2 %id)
TI_45215510   .f 250 to 747 456 to 957       801/957
(83 %)
21 diff
(97.9 %id)
TI_45216578   .f 250 to 844 400 to 992       875/1035
(84 %)
26 diff
(97.5 %id)
TI_44347991   .f 250 to 787 367 to 908       824/911
(90 %)
13 diff
(98.6 %id)
TI_44344914   .f 250 to 616 373 to 753       677/754
(89 %)
43 diff
(94.3 %id)
TI_44345236   .f 250 to 635 364 to 749       668/749
(89 %)
12 diff
(98.4 %id)
TI_44346074   .f 250 to 477 390 to 618       526/618
(85 %)
8 diff
(98.8 %id)
NM_002149.2   .f 250 to 1736 265 to 1751 exact RefSeq, AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 1751/1751
(100 %)
1 diff
(100.0 %id)
DA913399   .f 250 to 535 295 to 580   capped   579/580
(99 %)
8 diff
(98.7 %id)
DA922457 small intestine .f 250 to 260 275 to 285   capped   284/284
(100 %)
0 diff
(100 %id)
DN994242 brain, whole brain .f 250 to 626 302 to 678       675/678
(99 %)
6 diff
(99.2 %id)
BQ231144 epithelioid carcinoma, Pancreas .f 276 to 1173 1 to 907 exact     907/907
(100 %)
36 diff
(96.1 %id)
H14170 brain .f 283 to 528 1 to 246       246/249
(98 %)
8 diff
(96.8 %id)
CB122517 Liver .f 286 to 869 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BU500155   .f 293 to 802 1 to 510       510/724
(70 %)
7 diff
(99.1 %id)
BI223799 cervical carcinoma cell line, cervix .f 308 to 972 3 to 667 exact     665/667
(99 %)
0 diff
(100 %id)
BG331191 large cell carcinoma, lung .f 310 to 1087 2 to 765 D176E S188A S189V A190Q Q192V ...     764/938
(81 %)
20 diff
(97.9 %id)
AW804533 uterus .f 321 to 835 18 to 531       514/531
(96 %)
6 diff
(98.9 %id)
CR591594 T cells (Jurkat cell line) Cot10-normalized .f 332 to 1705 1 to 1374 exact tiling clone,   1374/1374
(100 %)
0 diff
(100 %id)
BX362119   .f 332 to 803 1 to 472   fully sequenced,   472/472
(100 %)
0 diff
(100 %id)
TI_1948099117   .f 352 to 925 122 to 695       574/594
(96 %)
6 diff
(99.0 %id)
TI_1948099265   .f 359 to 936 130 to 707       578/604
(95 %)
6 diff
(99.1 %id)
TI_1948099578   .f 359 to 861 125 to 627       503/529
(95 %)
6 diff
(98.9 %id)
BT009835   .f 360 to 939 1 to 580       580/582
(99 %)
1 diff
(99.9 %id)
CR541975   .f 360 to 941 1 to 582 exact     582/582
(100 %)
5 diff
(99.2 %id)
CV023732 mixed .f 360 to 940 1 to 581       581/675
(86 %)
1 diff
(99.9 %id)
TI_1948099425   .f 360 to 874 131 to 645   fully sequenced,   515/542
(95 %)
6 diff
(98.9 %id)
BF090321 nervous_normal .f 363 to 528 1 to 166       166/166
(100 %)
0 diff
(100 %id)
BE789293 large cell carcinoma, lung .f 407 to 1025 1 to 629       629/861
(73 %)
28 diff
(96.8 %id)
AW391924 stomach .f 412 to 823 1 to 412       412/412
(100 %)
0 diff
(100 %id)
CN264655 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 484 to 819 1 to 336       336/336
(100 %)
2 diff
(99.5 %id)
BF812152 colon_ins .f 494 to 905 30 to 440       411/444
(92 %)
9 diff
(98.0 %id)
BF810830 colon_ins .f 496 to 905 33 to 442       410/446
(91 %)
7 diff
(98.5 %id)
BI194435 epithelioid carcinoma cell line, Pancreas .f 514 to 1336 1 to 836       836/945
(88 %)
39 diff
(95.9 %id)
BM464008 melanotic melanoma, skin .f 523 to 1419 9 to 915       889/1115
(79 %)
28 diff
(97.5 %id)
CF127783 Chondrosarcoma Lung Metastasis cell lines, lung .f 524 to 1160 1 to 636       636/636
(100 %)
5 diff
(99.3 %id)
TI_154193461   .f 524 to 1258 52 to 787   AAA   736/1016
(72 %)
15 diff
(98.6 %id)
AW800900 uterus .f 527 to 835 16 to 324       309/330
(93 %)
12 diff
(96.4 %id)
BU500398   .f 534 to 1331 8 to 809       802/893
(89 %)
17 diff
(98.1 %id)
BF853739 lung_normal .f 547 to 1175 1 to 632       632/633
(99 %)
13 diff
(98.0 %id)
CV422253 bladder_tumor .f 547 to 974 435 to 5     Submitted on the opposite strand 431/435
(99 %)
8 diff
(98.2 %id)
BU500771   .f 552 to 1331 15 to 794       780/944
(82 %)
16 diff
(98.4 %id)
AA324827 brain, cerebellum .f 561 to 837 1 to 277       277/277
(100 %)
1 diff
(99.7 %id)
AA365710 pineal body .f 577 to 839 1 to 264       264/264
(100 %)
2 diff
(99.3 %id)
BQ233327 epithelioid carcinoma, Pancreas .f 587 to 1200 1 to 626       626/869
(72 %)
20 diff
(97.7 %id)
AV728984 hypothalamus .f 592 to 1038 1 to 447       447/447
(100 %)
0 diff
(100 %id)
BE076511 breast .f 595 to 826 237 to 6     Submitted on the opposite strand 232/237
(97 %)
0 diff
(100 %id)
BF091468 testis_normal .f 600 to 844 255 to 10       246/280
(87 %)
1 diff
(99.7 %id)
AF070616 brain .f 607 to 1736 1 to 1130   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 1130/1130
(100 %)
2 diff
(99.9 %id)
BG899301 cartilage .f 622 to 1106 78 to 562       485/494
(98 %)
6 diff
(98.8 %id)
DB456569 testis .f 626 to 1120 1 to 495       495/495
(100 %)
2 diff
(99.6 %id)
BX097532 whole brain .f 628 to 1156 11 to 539       529/539
(98 %)
7 diff
(98.8 %id)
R61643 whole brain .f 628 to 1033 10 to 420       411/424
(96 %)
23 diff
(94.6 %id)
BQ649810 hepatocellular carcinoma, cell line, Liver .f 629 to 1548 1 to 932       932/932
(100 %)
21 diff
(97.8 %id)
BQ653672 hepatocellular carcinoma, cell line, Liver .f 629 to 1384 1 to 774       774/886
(87 %)
31 diff
(96.6 %id)
BQ649273 hepatocellular carcinoma, cell line, Liver .f 629 to 1430 1 to 810       810/941
(86 %)
22 diff
(97.7 %id)
BX390822   .f 636 to 1556 1 to 932       932/958
(97 %)
53 diff
(94.5 %id)
BU845161 ovary, teratocarcinoma, cell line .f 673 to 1552 1 to 889       889/922
(96 %)
10 diff
(99.0 %id)
BM768954 stomach .f 696 to 1160 1 to 465       465/465
(100 %)
0 diff
(100 %id)
BM769505 stomach .f 696 to 1222 1 to 528       528/528
(100 %)
1 diff
(99.9 %id)
BQ083965 stomach .f 696 to 1003 1 to 308       308/308
(100 %)
0 diff
(100 %id)
BQ083881 stomach .f 696 to 1124 1 to 430       430/430
(100 %)
2 diff
(99.6 %id)
BI918630 brain .f 708 to 1568 1 to 876       876/970
(90 %)
25 diff
(97.5 %id)
TI_57238563   .f 708 to 1568 1 to 876       876/970
(90 %)
25 diff
(97.5 %id)
AL579031 placenta .f 734 to 1695 961 to 1       961/961
(100 %)
31 diff
(96.8 %id)
BF310660 brain, neuroblastoma .f 735 to 1356 1 to 629       629/968
(64 %)
28 diff
(97.2 %id)
BE166857 head_neck .f 738 to 1097 1 to 360       360/360
(100 %)
0 diff
(100 %id)
BE167549 head_neck .f 738 to 1002 1 to 265       265/271
(97 %)
5 diff
(98.2 %id)
CB108808 Liver .f 751 to 1322 1 to 572       572/572
(100 %)
1 diff
(99.9 %id)
BG490499 large cell carcinoma, lung .f 752 to 1427 1 to 674       674/674
(100 %)
7 diff
(99.0 %id)
BQ217815 large cell carcinoma, lung .f 755 to 1449 7 to 710       704/1141
(61 %)
30 diff
(97.4 %id)
BG331215 large cell carcinoma, lung .f 767 to 1547 1 to 777       777/995
(78 %)
25 diff
(97.5 %id)
AA453360   .f 768 to 1185 1 to 412   fully sequenced,   412/412
(100 %)
9 diff
(97.9 %id)
BX362118   .f 773 to 1701 932 to 5   fully sequenced,   928/932
(99 %)
0 diff
(100 %id)
AL577914 placenta .f 773 to 1691 919 to 1   fully sequenced,   919/919
(100 %)
8 diff
(99.2 %id)
BE876731 large cell carcinoma, undifferentiated, lung .f 789 to 1478 1 to 686       686/690
(99 %)
7 diff
(99.0 %id)
BF974958 B-cells, primary B-cells from tonsils (cell line) .f 791 to 1572 1 to 783       783/1078
(72 %)
29 diff
(97.4 %id)
BG685220 B-cells, primary B-cells from tonsils (cell line) .f 792 to 1448 1 to 659       659/760
(86 %)
16 diff
(97.9 %id)
BG759625 B-cells, primary B-cells from tonsils (cell line) .f 792 to 1556 1 to 772       772/772
(100 %)
19 diff
(97.6 %id)
AL561915 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .f 795 to 1694 898 to 1   fully sequenced,   898/898
(100 %)
7 diff
(99.3 %id)
DT220414 brain .f 802 to 1476 1 to 675       675/675
(100 %)
2 diff
(99.8 %id)
AL521768 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .f 813 to 1695 877 to 1   fully sequenced,   877/877
(100 %)
9 diff
(99.0 %id)
AL562348 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .f 813 to 1691 871 to 1   fully sequenced,   871/871
(100 %)
29 diff
(96.7 %id)
TI_1948099426   .f 813 to 940 253 to 126   fully sequenced,   128/253
(50 %)
0 diff
(100 %id)
AL580849 T cells from T cell leukemia .f 844 to 1662 852 to 39       814/820
(99 %)
0 diff
(100 %id)
BX414264 T cells (Jurkat cell line) .f 852 to 1711 869 to 1       869/877
(99 %)
47 diff
(94.7 %id)
AA453259   .f 942 to 1183 242 to 1   fully sequenced,   242/242
(100 %)
7 diff
(97.2 %id)
BX374192   .f 951 to 1704 758 to 3   fully sequenced,   756/758
(99 %)
24 diff
(96.9 %id)
AL563771 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .f 991 to 1670 684 to 8   fully sequenced,   677/684
(98 %)
18 diff
(97.4 %id)
CA389546 eye, RPE/choroid .f 1204 to 1721 532 to 15   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 518/518
(100 %)
5 diff
(99.1 %id)
BF966537 brain, hippocampus .f 1382 to 1665 325 to 37       709/1033
(68 %)
34 diff
(96.8 %id)
AW627629 2 pooled high-grade transitional celltumors, genitourinary tract .f 1408 to 1728 334 to 14   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 321/321
(100 %)
2 diff
(99.4 %id)
AK093973 uterus .g-u 1 to 2250 2 to 2247 exact tiling clone, available from FLJ,   2247/2247
(100 %)
6 diff
(99.8 %id)
AX748389   .g-u 1 to 2250 2 to 2247 exact     2247/2247
(100 %)
6 diff
(99.8 %id)
DB248481 uterus .g-u 1 to 602 2 to 603   capped   602/602
(100 %)
2 diff
(99.7 %id)
BF881171 lung_tumor .g-u 420 to 876 1 to 453       453/453
(100 %)
6 diff
(98.7 %id)
BM920441 pooled lung and spleen .g-u 465 to 1539 20 to 1093   tiling clone,   1074/1096
(97 %)
32 diff
(97.1 %id)
AA354447   .g-u 490 to 798 1 to 309       309/309
(100 %)
0 diff
(100 %id)
BE244587 leukopheresis .g-u 667 to 958 292 to 1       292/292
(100 %)
10 diff
(96.6 %id)
AW938684 denis_drash .g-u 825 to 1110 285 to 1     Submitted on the opposite strand 285/294
(96 %)
6 diff
(98.0 %id)
AI909850 breast .g-u 832 to 1102 1 to 271       271/280
(96 %)
2 diff
(99.3 %id)
AI909885 breast .g-u 832 to 1110 295 to 16       280/295
(94 %)
0 diff
(100 %id)
AI940079 colon .g-u 832 to 1110 279 to 1       279/279
(100 %)
1 diff
(99.7 %id)
AI940102 colon .g-u 832 to 1110 279 to 1       279/279
(100 %)
1 diff
(99.7 %id)
AW176490 colon .g-u 832 to 1110 279 to 1       279/279
(100 %)
1 diff
(99.7 %id)
AW844995 colon .g-u 832 to 1111 1 to 280       280/280
(100 %)
1 diff
(99.7 %id)
AW938670 denis_drash .g-u 832 to 1110 280 to 2     Submitted on the opposite strand 279/280
(99 %)
0 diff
(100 %id)
BF849685 lung_normal .g-u 1013 to 1344 342 to 11     Submitted on the opposite strand 332/342
(97 %)
0 diff
(100 %id)
BQ330595 lung_tumor .g-u 1178 to 1553 379 to 2       378/379
(99 %)
0 diff
(100 %id)
DB350967 uterus .g-u 1711 to 2250 536 to 1   tiling clone,   536/536
(100 %)
2 diff
(99.7 %id)
BG423025 Kidney, renal cell adenocarcinoma .h 1 to 788 1 to 792 A10P G11A A12Q A13Q A14L ... tiling clone,   792/826
(95 %)
23 diff
(97.3 %id)
BE544339 cervical carcinoma cell line, cervix .h 12 to 783 1 to 761   tiling clone,   761/888
(85 %)
36 diff
(96.0 %id)
BI256579 cervical carcinoma cell line, cervix .h 15 to 765 1 to 768       767/768
(99 %)
42 diff
(94.6 %id)
BE783055 eye, retinoblastoma .h 44 to 705 1 to 662   tiling clone,   662/662
(100 %)
1 diff
(99.9 %id)
BG610961 adenocarcinoma, Prostate .h 67 to 783 1 to 729   tiling clone,   729/836
(87 %)
21 diff
(97.5 %id)
BE546517 cervical carcinoma cell line, cervix .h 128 to 783 1 to 666   tiling clone,   666/852
(78 %)
22 diff
(97.5 %id)
BU150125 melanotic melanoma, cell line, skin .h 155 to 819 1 to 669   tiling clone,   669/749
(89 %)
16 diff
(97.9 %id)
BG751532 eye, normal pigmented retinal epithelium .i 250 to 650 271 to 672 S3L S5K R6P R7G T8G ... tiling clone,   672/672
(100 %)
14 diff
(98.0 %id)
BG752627 eye, normal pigmented retinal epithelium .i 250 to 684 269 to 703 H34R tiling clone,   703/706
(99 %)
4 diff
(99.5 %id)
BQ653888 hepatocellular carcinoma, cell line, Liver .j 1 to 795 19 to 829 C22G P23N G25P S26W H27K ... tiling clone,   811/968
(83 %)
62 diff
(93.6 %id)
CR749837 testis .k 1 to 4780 1 to 4780 H91R tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 4780/4780
(100 %)
18 diff
(99.7 %id)
DA851145 placenta .k 1188 to 1753 2 to 567   tiling clone, capped   566/566
(100 %)
1 diff
(99.9 %id)
DA523909 brain .k 1905 to 2461 2 to 558   tiling clone, capped   557/557
(100 %)
0 diff
(100 %id)
DB075807 testis .k 2353 to 2893 2 to 542   tiling clone, capped   541/541
(100 %)
0 diff
(100 %id)
DB138193 thymus .k 2545 to 3075 2 to 533   tiling clone, capped   532/532
(100 %)
1 diff
(99.9 %id)
AI909873 breast .k 3872 to 4119 7 to 255   tiling clone,   249/255
(97 %)
7 diff
(97.3 %id)
DB317359 brain .k 4489 to 5025 537 to 1       537/538
(99 %)
1 diff
(99.9 %id)
DB345173 thymus .k 4489 to 5030 542 to 1       542/542
(100 %)
0 diff
(100 %id)
DB328743 placenta .k 4490 to 5037 548 to 1   tiling clone,   548/548
(100 %)
0 diff
(100 %id)
AK126732 cerebellum .l-u 1 to 3262 2 to 3263 exact tiling clone, available from FLJ,   3263/3263
(100 %)
3 diff
(100.0 %id)
DA116015 cerebellum .l-u 1 to 597 2 to 598   capped   597/598
(99 %)
2 diff
(99.7 %id)
BG188914   .l-u 2021 to 2308 29 to 317       289/317
(91 %)
6 diff
(98.2 %id)
BG198845   .l-u 2025 to 2641 1 to 616       616/760
(81 %)
12 diff
(98.5 %id)
BG195927   .l-u 2042 to 2640 1 to 599       599/774
(77 %)
9 diff
(98.9 %id)
AI218064 pooled .l-u 2216 to 2517 304 to 3       302/304
(99 %)
0 diff
(100 %id)
CB136517 Liver .l-u 2481 to 2596 1 to 116       116/116
(100 %)
0 diff
(100 %id)
DB300190 cerebellum .l-u 2715 to 3262 549 to 1       549/549
(100 %)
5 diff
(99.1 %id)
BE616922 adenocarcinoma, colon .m 6 to 717 1 to 709   tiling clone,   709/935
(75 %)
21 diff
(97.8 %id)
CR599816 T cells (Jurkat cell line) .m 16 to 1845 1 to 1830 exact tiling clone,   1830/1830
(100 %)
0 diff
(100 %id)
AL556999 T cells (Jurkat cell line), T cells from T cell leukemia .m 16 to 910 1 to 893       893/975
(91 %)
6 diff
(99.4 %id)
DA117376 cerebellum .m 61 to 606 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
BI918757 brain .m 78 to 838 13 to 774       762/774
(98 %)
6 diff
(99.3 %id)
TI_57241137   .m 78 to 838 13 to 774       762/774
(98 %)
6 diff
(99.3 %id)
DA379618 thalamus .m 250 to 500 291 to 541   capped   540/540
(100 %)
3 diff
(99.5 %id)
BF724552 eye, Iris .m 250 to 415 285 to 450       450/450
(100 %)
1 diff
(99.8 %id)
BE891706 melanotic melanoma, skin .m 250 to 677 271 to 703       703/730
(96 %)
36 diff
(95.1 %id)
BG831293 epithelioid carcinoma cell line, Pancreas .m 250 to 914 269 to 935       935/975
(95 %)
50 diff
(94.9 %id)
BI834369 pooled pancreas and spleen .m 250 to 555 265 to 569       569/569
(100 %)
2 diff
(99.7 %id)
BQ898425 dorsal root ganglia .m 250 to 831 267 to 858       858/895
(95 %)
19 diff
(97.9 %id)
TI_57163920   .m 250 to 813 300 to 859       830/859
(96 %)
17 diff
(98.1 %id)
DB247909 uterus .m 250 to 421 290 to 464   capped   463/463
(100 %)
4 diff
(99.2 %id)
BQ675758 epidermoid carcinoma, cell line, salivary gland .m 475 to 1006 1 to 536       536/1142
(46 %)
12 diff
(99.0 %id)
BU163704 epidermoid carcinoma, cell line, salivary gland .m 475 to 1243 1 to 784 D111X E140X S189R A190G S191Q ...     784/953
(82 %)
25 diff
(97.4 %id)
AL579108 T cells (Jurkat cell line), T cells from T cell leukemia .m 907 to 1840 933 to 6       928/1088
(85 %)
1 diff
(100.0 %id)
AA301719 aorta .m 1031 to 1373 1 to 347       347/347
(100 %)
10 diff
(97.2 %id)
AA042958 uterus .m 1036 to 1464 1 to 439       439/440
(99 %)
13 diff
(97.1 %id)
BM738147 Ascites, stomach .m 1036 to 1549 8 to 519       512/519
(98 %)
6 diff
(98.9 %id)
BM759604 Ascites, stomach .m 1036 to 1610 9 to 583       575/583
(98 %)
6 diff
(99.0 %id)
BM760617 lymph node, stomach .m 1042 to 1248 1 to 206       206/206
(100 %)
1 diff
(99.6 %id)
BM760453 lymph node, stomach .m 1042 to 1204 1 to 164       164/164
(100 %)
1 diff
(99.4 %id)
BM764269 lymph node, stomach .m 1042 to 1505 1 to 464       464/464
(100 %)
1 diff
(99.8 %id)
BM841888 lymph node, stomach .m 1042 to 1493 1 to 452       452/452
(100 %)
1 diff
(99.8 %id)
BM841727 lymph node, stomach .m 1042 to 1529 1 to 488       488/488
(100 %)
3 diff
(99.4 %id)
BM838398 lymph node, stomach .m 1053 to 1477 1 to 425       425/425
(100 %)
1 diff
(99.8 %id)
TI_227712918   .m 1055 to 1894 907 to 79   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 829/977
(84 %)
18 diff
(98.2 %id)
BM708335 eye, RPE and Choroid .m 1056 to 1462 1 to 408   fully sequenced, Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 408/408
(100 %)
0 diff
(100 %id)
BM050285 eye, normal pigmented retinal epithelium .m 1064 to 1804 1 to 745       745/746
(99 %)
24 diff
(96.8 %id)
BQ636000 eye, retina .m 1074 to 1730 1 to 657       657/657
(100 %)
1 diff
(99.9 %id)
BG388207 embryonal carcinoma, cell line, testis .m 1084 to 1833 1 to 756       756/924
(81 %)
18 diff
(98.1 %id)
CD367290 Alveolar Macrophage, lung .m 1091 to 1894 810 to 14   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 797/798
(99 %)
9 diff
(98.9 %id)
BG753024 eye, normal pigmented retinal epithelium .m 1095 to 1810 1 to 716       716/717
(99 %)
5 diff
(99.4 %id)
AI870506 anaplastic oligodendroglioma, brain .m 1101 to 1902 806 to 8       799/806
(99 %)
0 diff
(100 %id)
TI_159705502   .m 1110 to 1894 808 to 32   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 777/990
(78 %)
19 diff
(98.1 %id)
BE617588 adenocarcinoma, colon .m 1117 to 1842 755 to 2       754/1214
(62 %)
0 diff
(100 %id)
TI_149295226   .m 1124 to 1894 846 to 85   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 762/921
(82 %)
15 diff
(98.4 %id)
BQ673632 epidermoid carcinoma, cell line, salivary gland .m 1147 to 1757 1 to 611       611/940
(65 %)
25 diff
(97.4 %id)
BE910295 epithelioid carcinoma, Pancreas .m 1152 to 1866 732 to 1     Submitted on the opposite strand 732/773
(94 %)
37 diff
(95.3 %id)
BQ224614 epithelioid carcinoma, Pancreas .m 1153 to 1906 819 to 59   AAA Submitted on the opposite strand 761/836
(91 %)
0 diff
(100 %id)
AI417375 anaplastic oligodendroglioma, brain .m 1160 to 1902 735 to 8       728/739
(98 %)
0 diff
(100 %id)
TI_154130224   .m 1164 to 1901 820 to 89   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 732/940
(77 %)
11 diff
(98.9 %id)
BQ574930 Chondrosarcoma Grade II, Left Pelvis .m 1177 to 1894 734 to 19   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 716/716
(100 %)
4 diff
(99.5 %id)
TI_151699343   .m 1181 to 1883 773 to 78       696/1003
(69 %)
0 diff
(100 %id)
BQ675677 epidermoid carcinoma, cell line, salivary gland .m 1197 to 1651 1 to 455       455/1064
(42 %)
9 diff
(99.2 %id)
AA346219 NULL, omentum .m 1213 to 1437 1 to 225       225/225
(100 %)
0 diff
(100 %id)
BX355120 Neuroblastoma Cot 50-normalized .m 1223 to 1897 1 to 674       674/674
(100 %)
2 diff
(99.8 %id)
BM985335 lung .m 1227 to 1894 680 to 14   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 667/667
(100 %)
3 diff
(99.6 %id)
BM547621 brain, hippocampus .m 1229 to 1891 1 to 663       663/665
(99 %)
2 diff
(99.7 %id)
AI870508 anaplastic oligodendroglioma, brain .m 1238 to 1900 669 to 10       660/669
(98 %)
0 diff
(100 %id)
AA352363   .m 1246 to 1466 1 to 221       221/221
(100 %)
1 diff
(99.6 %id)
AI866667 brain, tumor, 5 pooled (see description) .m 1247 to 1901 671 to 20   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 652/660
(98 %)
12 diff
(98.2 %id)
BF130127 hypernephroma, Kidney .m 1250 to 1869 1 to 609       609/643
(94 %)
18 diff
(97.3 %id)
AA316328 colon .m 1255 to 1707 1 to 450       450/450
(100 %)
3 diff
(99.4 %id)
AI560894 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .m 1260 to 1901 661 to 26   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 636/648
(98 %)
34 diff
(94.8 %id)
AW467522 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .m 1264 to 1909 645 to 1       645/645
(100 %)
20 diff
(96.9 %id)
AW073355 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .m 1265 to 1895 631 to 1       631/636
(99 %)
14 diff
(97.8 %id)
TI_154020635   .m 1281 to 1901 708 to 88   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 621/687
(90 %)
3 diff
(99.6 %id)
CA438581 lung, Metastatic Chondrosarcoma .m 1281 to 1901 639 to 19   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 621/623
(99 %)
3 diff
(99.6 %id)
CB530018 Aveolar Macrophage, lung .m 1281 to 1894 627 to 14   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 614/614
(100 %)
0 diff
(100 %id)
BG122949 adenocarcinoma, cell line, Liver .m 1285 to 1903 1 to 616       616/668
(92 %)
12 diff
(98.3 %id)
BQ000020 Fibrosarcoma .m 1290 to 1894 618 to 14   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 605/605
(100 %)
0 diff
(100 %id)
CA419164 Chondrosarcoma Grade II, Left Pelvis .m 1290 to 1901 630 to 19   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 612/612
(100 %)
0 diff
(100 %id)
BM857150 stomach .m 1320 to 1804 1 to 485       485/485
(100 %)
2 diff
(99.6 %id)
TI_151768129   .m 1322 to 1902 108 to 688   AAA   581/841
(69 %)
7 diff
(99.2 %id)
BQ448550 Knee, Osteoarthritic Cartilage .m 1329 to 1901 591 to 19   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 573/573
(100 %)
0 diff
(100 %id)
CA309385 Alveolar Macrophage, lung .m 1336 to 1889 569 to 17   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 553/553
(100 %)
1 diff
(99.9 %id)
BM988572 lung, Metastatic Chondrosarcoma .m 1369 to 1894 539 to 14   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 526/534
(98 %)
0 diff
(100 %id)
BU731413 eye, RPE and Choroid .m 1384 to 1901 536 to 19   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 518/518
(100 %)
2 diff
(99.7 %id)
DB570372 hypothalamus .m 1387 to 1901 1 to 515     Submitted on the opposite strand 515/515
(100 %)
1 diff
(99.9 %id)
DB570084 hypothalamus .m 1390 to 1894 1 to 505     Submitted on the opposite strand 505/505
(100 %)
3 diff
(99.5 %id)
CK820261 Islets of Langerhans, Pancreas .m 1396 to 1889 1 to 494   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 494/494
(100 %)
0 diff
(100 %id)
BM142345 Islets of Langerhans, Pancreas .m 1412 to 1881 1 to 470       470/470
(100 %)
0 diff
(100 %id)
DB572511 hypothalamus .m 1416 to 1894 1 to 479   AAA Submitted on the opposite strand 479/479
(100 %)
0 diff
(100 %id)
DB575199 hypothalamus .m 1416 to 1894 1 to 479     Submitted on the opposite strand 479/479
(100 %)
1 diff
(99.8 %id)
CK820260 Islets of Langerhans, Pancreas .m 1417 to 1895 479 to 1       479/479
(100 %)
0 diff
(100 %id)
DB568137 hypothalamus .m 1418 to 1901 1 to 484     Submitted on the opposite strand 484/484
(100 %)
2 diff
(99.6 %id)
R38759 whole brain .m 1420 to 1910 506 to 9       498/506
(98 %)
0 diff
(100 %id)
AI142457 uterus .m 1422 to 1895 474 to 1       474/474
(100 %)
0 diff
(100 %id)
DB552782 hippocampus .m 1423 to 1901 1 to 479     Submitted on the opposite strand 479/479
(100 %)
0 diff
(100 %id)
DB539535 hippocampus .m 1424 to 1894 1 to 471     Submitted on the opposite strand 471/471
(100 %)
1 diff
(99.8 %id)
F37476 pectoral muscle (after mastectomy) .m 1425 to 1769 15 to 359       345/359
(96 %)
6 diff
(98.4 %id)
DB572307 hypothalamus .m 1426 to 1894 1 to 469   AAA Submitted on the opposite strand 469/469
(100 %)
0 diff
(100 %id)
BE930562 placenta_normal .m 1431 to 1789 361 to 2       360/366
(98 %)
0 diff
(100 %id)
DB521986 testis .m 1432 to 1894 1 to 463   AAA Submitted on the opposite strand 463/463
(100 %)
0 diff
(100 %id)
BU732101 eye, RPE and Choroid .m 1432 to 1894 480 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 462/462
(100 %)
0 diff
(100 %id)
DB552400 hippocampus .m 1436 to 1899 1 to 464     Submitted on the opposite strand 464/466
(99 %)
2 diff
(99.6 %id)
DB573063 hypothalamus .m 1441 to 1894 1 to 454     Submitted on the opposite strand 454/454
(100 %)
1 diff
(99.8 %id)
DB577793 hypothalamus .m 1445 to 1897 1 to 453     Submitted on the opposite strand 453/455
(99 %)
1 diff
(99.8 %id)
AI923791 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .m 1445 to 1893 449 to 1       449/449
(100 %)
0 diff
(100 %id)
AW079873 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .m 1446 to 1894 450 to 1       450/450
(100 %)
3 diff
(99.4 %id)
AW471050 colon, moderately-differentiated adenocarcinoma .m 1448 to 1902 457 to 3       455/457
(99 %)
0 diff
(100 %id)
DB552361 hippocampus .m 1451 to 1907 1 to 457     Submitted on the opposite strand 457/459
(99 %)
2 diff
(99.6 %id)
AI813928 adenocarcinoma, Pancreas .m 1452 to 1896 445 to 1       445/445
(100 %)
1 diff
(99.8 %id)
AI566904 anaplastic oligodendroglioma, brain .m 1453 to 1902 467 to 19   AAA   449/456
(98 %)
0 diff
(100 %id)
DB564359 hypothalamus .m 1454 to 1901 1 to 448     Submitted on the opposite strand 448/448
(100 %)
0 diff
(100 %id)
AI128088 uterus .m 1454 to 1894 454 to 14   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 441/441
(100 %)
2 diff
(99.6 %id)
BM142520 Islets of Langerhans, Pancreas .m 1456 to 1895 440 to 1       440/440
(100 %)
0 diff
(100 %id)
AI890801 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .m 1457 to 1897 445 to 5       441/445
(99 %)
0 diff
(100 %id)
H19857 brain .m 1469 to 1886 1 to 410       410/416
(98 %)
16 diff
(96.2 %id)
AA918897 Kidney .m 1471 to 1896 425 to 1       425/425
(100 %)
1 diff
(99.8 %id)
AI143818 heart .m 1472 to 1901 430 to 1       430/430
(100 %)
2 diff
(99.6 %id)
AI672941 colon, colonic mucosa from 3 patients with Crohn'sdisease .m 1472 to 1686 422 to 208   AAA   215/404
(53 %)
0 diff
(100 %id)
AA991312 breast .m 1475 to 1893 419 to 1       419/419
(100 %)
0 diff
(100 %id)
TI_154092641   .m 1482 to 1897 509 to 94       416/1046
(39 %)
0 diff
(100 %id)
CA434569 lung, Lung Focal Fibrosis .m 1482 to 1897 431 to 16       416/436
(95 %)
0 diff
(100 %id)
DB558778 hypothalamus .m 1484 to 1901 1 to 416     Submitted on the opposite strand 416/416
(100 %)
18 diff
(95.7 %id)
AA937144 2 pooled tumors (clear cell type), Kidney .m 1486 to 1894 411 to 1       411/411
(100 %)
4 diff
(99.1 %id)
DB556560 hypothalamus .m 1492 to 1901 1 to 410     Submitted on the opposite strand 410/410
(100 %)
5 diff
(98.8 %id)
DB557953 hypothalamus .m 1492 to 1894 1 to 398     Submitted on the opposite strand 398/398
(100 %)
26 diff
(93.5 %id)
DB533301 hippocampus .m 1493 to 1899 1 to 408     Submitted on the opposite strand 408/410
(99 %)
2 diff
(99.6 %id)
DB536573 hippocampus .m 1495 to 1901 1 to 409     Submitted on the opposite strand 409/409
(100 %)
6 diff
(98.6 %id)
AA864413 Kidney, kidney tumor .m 1495 to 1895 401 to 1       401/401
(100 %)
3 diff
(99.3 %id)
AI146554 brain, glioblastoma (pooled) .m 1495 to 1901 427 to 22   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 406/406
(100 %)
4 diff
(99.1 %id)
AI538344 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .m 1508 to 1894 387 to 1       387/387
(100 %)
0 diff
(100 %id)
AW510926 pooled .m 1508 to 1896 389 to 1       389/389
(100 %)
0 diff
(100 %id)
AA042818 uterus .m 1512 to 1901 395 to 1       395/396
(99 %)
4 diff
(99.0 %id)
BU789332 insulinoma, Pancreas .m 1514 to 1889 8 to 383   fully sequenced, AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 376/383
(98 %)
0 diff
(100 %id)
AW192112 adenocarcinoma, Pancreas .m 1518 to 1897 383 to 4       380/383
(99 %)
0 diff
(100 %id)
BG055909 anaplastic oligodendroglioma, brain .m 1524 to 1902 384 to 6       379/384
(98 %)
0 diff
(100 %id)
BG163324 hypernephroma, cell line, Kidney .m 1527 to 1894 1 to 368   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 368/368
(100 %)
0 diff
(100 %id)
AI263262 lung .m 1531 to 1895 366 to 1       366/366
(100 %)
6 diff
(98.4 %id)
BE258519 eye, retinoblastoma .m 1538 to 1900 1 to 363       363/363
(100 %)
0 diff
(100 %id)
AW673070 cervical carcinoma cell line, cervix .m 1543 to 1897 356 to 2       355/356
(99 %)
0 diff
(100 %id)
AA425260.
matches multiple genes
  .m 1566 to 1894 357 to 29   AAA Submitted on the opposite strand, also hits gene SETD8 329/329
(100 %)
0 diff
(100 %id)
BE172629 head_neck .m 1573 to 1823 284 to 34     Submitted on the opposite strand 251/284
(88 %)
0 diff
(100 %id)
AA970853 2 pooled tumors (clear cell type), Kidney .m 1581 to 1894 314 to 1       314/314
(100 %)
0 diff
(100 %id)
CR607303 Placenta Cot 25-normalized .m 1588 to 1897 1 to 310       310/310
(100 %)
0 diff
(100 %id)
BX359177 Placenta Cot 25-normalized .m 1588 to 1897 1 to 309       309/309
(100 %)
1 diff
(99.7 %id)
DB558408 hypothalamus .m 1588 to 1897 100 to 410     Submitted on the opposite strand 311/412
(75 %)
2 diff
(99.6 %id)
AA904152 carcinoid, lung .m 1591 to 1902 313 to 2       312/313
(99 %)
0 diff
(100 %id)
AI445112 colon, moderately-differentiated adenocarcinoma .m 1595 to 1901 307 to 1       307/307
(100 %)
0 diff
(100 %id)
AW084081 colon, moderately differentiated adenocarcinoma .m 1595 to 1909 326 to 12   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 315/315
(100 %)
0 diff
(100 %id)
TI_154024224   .m 1595 to 1894 51 to 350   AAA Submitted on the opposite strand 300/350
(85 %)
6 diff
(98.3 %id)
BE858083 brain, glioblastoma (pooled) .m 1597 to 1901 305 to 1       305/305
(100 %)
1 diff
(99.7 %id)
CA439525 lung, Lung Focal Fibrosis .m 1605 to 1894 1 to 290   AAA Submitted on the opposite strand 290/290
(100 %)
5 diff
(98.3 %id)
AA402860 ovarian tumor, ovary .m 1617 to 1908 291 to 1       291/291
(100 %)
1 diff
(99.7 %id)
AA451708   .m 1617 to 1910 297 to 4       294/297
(98 %)
0 diff
(100 %id)
BF055435 pooled .m 1644 to 1897 259 to 6       254/259
(98 %)
0 diff
(100 %id)
AA627598 colon, colon tumor RER+ .m 1661 to 1894 233 to 1       233/233
(100 %)
1 diff
(99.6 %id)
AW571917 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .m 1678 to 1910 234 to 2   tiling clone,   233/234
(99 %)
0 diff
(100 %id)
BU789070 insulinoma, Pancreas .m 1686 to 1894 224 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 209/209
(100 %)
0 diff
(100 %id)
DB561789 hypothalamus .m 1692 to 1899 17 to 224     Submitted on the opposite strand 208/226
(92 %)
12 diff
(94.7 %id)
AA902426 carcinoid, lung .m 1703 to 1897 196 to 2       195/196
(99 %)
0 diff
(100 %id)
AA018155.
matches multiple genes
eye, retina .m 1714 to 1894 181 to 1     also hits gene toslyby 181/217
(83 %)
5 diff
(97.7 %id)
DV462212 cochlea, ear .m 1728 to 1901 192 to 18   AAA Submitted on the opposite strand 175/175
(100 %)
2 diff
(98.9 %id)
AW836980 leiomios .m 1729 to 1852 134 to 11       124/134
(92 %)
0 diff
(100 %id)
AA565191 adrenal adenoma, adrenal gland .m 1739 to 1895 157 to 1       157/157
(100 %)
0 diff
(100 %id)
BM681885 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .m 1742 to 1897 3 to 158     Submitted on the opposite strand 156/173
(90 %)
6 diff
(96.6 %id)
BM723701 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .m 1742 to 1897 162 to 7     Submitted on the opposite strand 156/175
(89 %)
0 diff
(100 %id)
CD389356 embryonic trophoblasts, made from WA01 stemcells .m 1743 to 1901 27 to 185   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 159/185
(85 %)
6 diff
(96.8 %id)
DB562651 hypothalamus .m 1755 to 1901 1 to 147     Submitted on the opposite strand 147/147
(100 %)
2 diff
(98.7 %id)
AW089688 ovary, tumor, 5 pooled (see description) .m 1774 to 1837 61 to 124     Submitted on the opposite strand 64/125
(51 %)
1 diff
(99.2 %id)
BE857389 brain, glioblastoma (pooled) .m 1778 to 1901 124 to 1       124/126
(98 %)
3 diff
(97.7 %id)
EC489657 Prostate .m 1791 to 1887 97 to 1       97/97
(100 %)
0 diff
(100 %id)
EC541652 Prostate .m 1794 to 1893 102 to 3       100/102
(98 %)
0 diff
(100 %id)
D11978 Liver .m 1801 to 1889 1 to 89       89/89
(100 %)
0 diff
(100 %id)
D12000 Liver .m 1801 to 1886 1 to 86       86/94
(91 %)
1 diff
(99.0 %id)
NM_134421.1   .n 1 to 1903 1 to 1903 exact RefSeq, AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 1903/1903
(100 %)
4 diff
(99.8 %id)
AK000596   .n 8 to 1903 14 to 1909 exact tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 1896/1896
(100 %)
3 diff
(99.9 %id)
BG775557 carcinoma, cell line, Prostate .o 1 to 882 4 to 885   tiling clone,   885/888
(99 %)
7 diff
(99.3 %id)
BM923589 pooled colon, kidney, stomach .o 250 to 699 336 to 793       722/1356
(53 %)
25 diff
(98.2 %id)
BM847683 myeloma .o 321 to 872 1 to 551       551/551
(100 %)
4 diff
(99.3 %id)
BM764165 myeloma .o 322 to 874 1 to 553   tiling clone,   553/553
(100 %)
0 diff
(100 %id)
BG775825 carcinoma, cell line, Prostate .o 961 to 1891 936 to 1   tiling clone,   936/967
(96 %)
28 diff
(97.2 %id)
CB125906 Liver .p 58 to 546 1 to 489   tiling clone,   489/489
(100 %)
2 diff
(99.6 %id)
AL555349 placenta .p 250 to 787 271 to 810   tiling clone,   810/810
(100 %)
5 diff
(99.4 %id)
AL558625 T cells from T cell leukemia .p 370 to 773 1 to 403       403/403
(100 %)
9 diff
(97.8 %id)
BP307864 brain .p 673 to 1259 1 to 587   tiling clone,   587/587
(100 %)
1 diff
(99.9 %id)
BM044413 carcinoma, cell line, Prostate .p 958 to 1591 1 to 634   tiling clone,   634/634
(100 %)
3 diff
(99.6 %id)
AL580405 T cells from T cell leukemia .p 982 to 1818 850 to 18   tiling clone,   833/850
(98 %)
0 diff
(100 %id)
AL577875 placenta .p 982 to 1793 810 to 1   tiling clone,   810/810
(100 %)
7 diff
(99.2 %id)
DB473805 hippocampus .q 1 to 490 1 to 491   tiling clone,   491/491
(100 %)
4 diff
(99.2 %id)
DA129489 alzheimer cortex .q 13 to 567 2 to 556   tiling clone, capped   555/555
(100 %)
2 diff
(99.7 %id)
DB501318 hypothalamus .q 107 to 605 1 to 499 P39T tiling clone,   499/499
(100 %)
2 diff
(99.6 %id)
DB039642 testis .r 1 to 576 2 to 577 exact tiling clone, capped   576/576
(100 %)
1 diff
(99.9 %id)
DA685332   .s 1 to 576 2 to 578 exact tiling clone, capped   577/577
(100 %)
2 diff
(99.7 %id)
DB035570 testis .t 1 to 556 2 to 558 exact tiling clone, capped   557/557
(100 %)
3 diff
(99.5 %id)
DA136583 alzheimer cortex .u 1 to 547 2 to 548 exact tiling clone, capped   547/547
(100 %)
1 diff
(99.9 %id)
DB250509 uterus .va 250 to 546 290 to 586 exact tiling clone, capped   585/585
(100 %)
1 diff
(99.9 %id)
AW062736 colon .vb-u 1 to 520 17 to 536 T8I Q9S Q10R G11I W12G ... tiling clone,   520/536
(97 %)
6 diff
(98.9 %id)
DA072912 cerebellum Gene HPCAL1, variant not shown       capped      
DB470952 hippocampus Gene HPCAL1, variant not shown         Suspected internal deletion, this clone was ignored    
DA590884 lung Gene HPCAL1, variant not shown       capped      
AA602858 breast, breast tumor Gene HPCAL1, variant not shown         Suspected internal deletion, this clone was ignored    
AA723915 pooled Gene HPCAL1, variant not shown         Suspected internal deletion, this clone was ignored    
AI160551 uterus Gene HPCAL1, variant not shown         Suspected internal deletion, this clone was ignored    
BG330883 large cell carcinoma, lung Gene HPCAL1, variant not shown         This clone was ignored    
BI834882 pooled pancreas and spleen Gene HPCAL1, variant not shown         This clone was ignored    
BI601973 brain, hypothalamus Gene HPCAL1, variant not shown              
BU190761 ductal carcinoma, cell line, Pancreas Gene HPCAL1, variant not shown       AAA This clone was ignored    
BU157912 ductal carcinoma, cell line, Pancreas Gene HPCAL1, variant not shown         This clone was ignored    
BU180151 ductal carcinoma, cell line, Pancreas Gene HPCAL1, variant not shown         This clone was ignored    
BQ431369 melanotic melanoma, skin Gene HPCAL1, variant not shown              
BQ685527 ductal carcinoma, cell line, Pancreas Gene HPCAL1, variant not shown         This clone was ignored    
BQ685422 ductal carcinoma, cell line, Pancreas Gene HPCAL1, variant not shown         This clone was ignored    
CB133125 Liver Gene HPCAL1, variant not shown         This clone was ignored    
AU310948 neuroblastoma Gene HPCAL1, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AU310947 neuroblastoma Gene HPCAL1, variant not shown         Suspected internal deletion, this clone was ignored    
DB271271 uterus Gene HPCAL1, variant not shown       capped This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g-u, .h, .i, .j, .k, .l-u, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI